Navigation Links
Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
Date:9/22/2010

WALTHAM, Mass., Sept. 22 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that Joanna Horobin, M.D., the company's president and CEO, will present at the Sachs Biotech in Europe Investor Forum Wednesday, September 29, 2010 at the Radisson Blu hotel in Zurich, Switzerland.

Dr. Horobin will be a panelist on the Oncology Investment Panel at 12:00 pm CEST.  Her presentation will be given at 5:00 p.m. CEST and will include an overview of upcoming milestones including the ongoing phase 2 clinical program for entinostat in breast, lung, colorectal cancer and hematologic malignancies.

The presentation will be available at Syndax's website, www.syndax.com.

About SyndaxSyndax Pharmaceuticals, Inc. is a Waltham, MA-based, oncology-focused pharmaceutical company. Syndax is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens. Formed in 2005, the company's intellectual property is based on work from scientific founder Ronald Evans, Ph.D., recipient of the 2004 Albert Lasker Prize for Basic Medical Research, a Member of the National Academy of Sciences, a professor at the Salk Institute for Biological Studies and a Howard Hughes Medical Institute Investigator.

Syndax holds rights to entinostat from Bayer Schering Pharma and is backed by top-tier Venture Capital firms: Domain Associates, MPM Capital, Avalon, Pappas and Forward Ventures.  For more information please visit www.syndax.com.Contact InformationJoanna Horobin, M.D.

Danielle Bertrand Syndax Pharmaceuticals, Inc.

WCG Tel: 781-419-1402

Tel: 415-946-1056 jhorobin@syndax.com

dbertrand@wcgworl
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
2. Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
3. Access Pharmaceuticals, Inc. Signs $30M MuGard Supply Agreement With RHEI Pharmaceuticals HK LTD.
4. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
5. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceuticals
6. NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments
7. Lead Plaintiffs Attorney In Forest Pharmaceuticals Case Says $313 Million Award Is Tip of the Iceberg of Future Off-Label Marketing Lawsuits
8. Cempra Pharmaceuticals to Present at the UBS Global Life Sciences Conference
9. HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada
10. Onyx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
11. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... DUBLIN , May 05, 2015 Research ... announced the addition of the "Chromatography (Instruments ... report to their offering. Chromatography ... and identifying the component of a complex mixture ... Over the decades the scientists have considered chromatography ...
(Date:5/6/2015)... May 6, 2015   CEFALY Technology , the ... device specifically authorized for use prior to the onset ... in migraine treatment at the EUROHEADPAIN - Midterm Meeting ... Valencia, Spain , from May 14-17, 2015. ... of EUROHEADPAIN, a major European research project focused on ...
(Date:5/6/2015)... Advanced wound care - assess products, developments, ... future hold for the advanced wound care ... potential revenues to 2025, assessing data, trends, opportunities and ... provides 115 tables, charts, and graphs covering 12 distinct ... industry and the future market prospects. You will see ...
Breaking Medicine Technology:Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today ... exchange up to $180,000,000 in aggregate principal amount of outstanding ... like principal amount of new 2.875% Series 2012 Convertible Senior ... name of the New Notes has been amended from the ...
... Pa., Jan. 3, 2012  The board of directors of Kensey ... the board has declared a cash dividend of $0.25 ... stockholders of record on January 31, 2012.  The dividend will ... initial dividend under a new policy whereby the board of ...
Cached Medicine Technology:PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer 2Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 2Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 3Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 4
(Date:5/6/2015)... May 06, 2015 The Beryl Institute ... of Patient Experience Journal (PXJ), an international, open ... around understanding and improving patient experience. The second volume ... experience conversation globally, helps align the voices engaged and ... , Published in association with The Beryl Institute, Volume ...
(Date:5/6/2015)... 06, 2015 Is Colorado’s legal cannabis ... month the Centennial State will mark the 18-month milestone ... to adults. And while Colorado’s legal marijuana industry has ... time, it’s also facing some new challenges. , For ... facing shortages, especially in the wake of last month’s ...
(Date:5/6/2015)... vcfo, a specialized consulting firm that provides access ... optimize business performance and productivity, announced the additions of ... Both Lynch and Scheaffer have more than 25 years ... are delighted to add Jack and Mike to the ... in financial management and leadership, Mike and Jack will ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup ... China, has successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction ... Anitoa’s handheld qPCR is shown to be capable of ... hepatitis B, C, and E. Coli. This qPCR system ... and over 9 orders of magnitude dynamic range. ...
(Date:5/6/2015)... 2015 Locally owned, Greek olive oil producer ... past week as having one the best Extra Virgin Olive ... the Peloponnese region of Greece and known as Laconiko ... category of Medium Olive Oil, which is defined by the ... With over 700 producer applicants from 25 different countries applying, ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2
... non-invasive way to determine the existence and extent of ... pharmacologic strategies to combat the condition. These findings are ... by John Wiley & Sons on behalf of the ... The article is also available online at Wiley Interscience ...
... Dr. Yukai He wants to put cancer in the bulls eye. ... Cancer Center immunologist says of the scary reality that cancer cells ... doesnt always see cancer as a horrific invader. , Tumors and ... main player in anti-tumor immunity, cohabitate for many years before the ...
... disability in the United States. Over the next 25 ... toll of this disease will escalate. To have a ... on our nations health care and public health systems, estimating ... arthritisis critical. , The National Arthritis Data Workgroup was formed ...
... R. Bloomberg, Health Commissioner Dr. Thomas R. Frieden, and Consumer ... 2007 New York City Youth Risk Behavior Survey (YRBS) showing ... 20 percent between 2005 and 2007. The citys teen smoking ... six years, from 17.6 percent in 2001 to 8.5 percent ...
... in red wine grapes may significantly reduce the ability ... published recently in the Journal of Agricultural and Food ... large amounts in fermented seeds and skins cast away ... bacteria to contribute to tooth decay. Beyond cavities, the ...
... of Medicine (BUSM) have found that vitamin D2 is equally ... The study appears online in the December 2007 issue ... studied healthy adults aged 18-84 who received either placebo, 1,000 ... D2, or 500 IU of vitamin D2 plus 500 IU ...
Cached Medicine News:Health News:MRI techniques evolving towards better assessment of liver fibrosis 2Health News:New strategies work to put cancer on the firing line 2Health News:New strategies work to put cancer on the firing line 3Health News:The prevalence and impact of arthritis and other rheumatic conditions in the United States 2Health News:The prevalence and impact of arthritis and other rheumatic conditions in the United States 3Health News:Smoking rate among New York City teens was lowest on record in 2007 2Health News:Smoking rate among New York City teens was lowest on record in 2007 3Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 2Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 3Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 4Health News:Vitamin D2 is as effective as vitamin D3 in maintaining concentrations of 25-hydroxyvitamin D 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: